Sinovac Biotech (SVA)

QUOTE AND NEWS
SeekingAlpha  Mar 20  Comment 
Sinovac Biotech Ltd. (SVA) Q4 2013 Earnings Conference Call March 20, 2014 08:00 ET Executives Stephanie Carrington - The Ruth Group, Investor Relations Weidong Yin - Chief Executive Officer Nan Wang - Chief Financial Officer ...
Benzinga  Mar 20  Comment 
Sinovac Biotech (NASDAQ: SVA) shares touched a new 52-week high of $7.60 after the company reported unaudited Q4 results. Sinovac Biotech posted its quarterly net income of $5.8 million, or $0.10 per share, versus a year-ago net loss of $4.6...
StreetInsider.com  Mar 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Sinovac+Biotech%2C+Ltd+%28SVA%29+Posts+Q4+EPS+of+10c/9300998.html for the full story.
Benzinga  Mar 20  Comment 
Synta Pharmaceuticals (NASDAQ: SNTA) surged 30.53% to $6.20 in the pre-market session on positive interim results from the ENCHANT-1 trial of ganetespib in metastatic breast cancer. Sinovac Biotech (NASDAQ: SVA) shares gained 8.85% to $7.50 in...
SeekingAlpha  Mar 17  Comment 
By Chris Katje: On February 26th, Sinovac (SVA) shares were up over 5% after the New England Journal of Medicine published the Phase III results of the company's EV71 vaccine. This vaccine could be the biggest catalyst for shares of Sinovac going...
DailyFinance  Feb 19  Comment 
SYDNEY, AUSTRALIA -- (Marketwired) -- 02/18/14 -- Simavita Limited (ASX: SVA)(TSX VENTURE: SV) is delighted to announce that it will be admitted to the Official List of ASX Limited, with trading to expected to commence on Thursday, February 20,...
Benzinga  Nov 13  Comment 
In a report published Wednesday, Aegis Capital analyst Raghuram Selvaraju reiterated a Buy rating and $7.00 price target on Sinovac Biotech (NASDAQ: SVA). In the report, Aegis Capital Corp. noted, “Yesterday after the market close, Sinovac...
StreetInsider.com  Nov 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Sinovac+Biotech%2C+Ltd+%28SVA%29+Posts+Q3+Profit+of+4cShare/8878825.html for the full story.
Benzinga  Sep 9  Comment 
Sinovac Biotech (NASDAQ: SVA) shares gained 6.15% to touch a new 52-week high of $6.04. Sinovac shares have jumped 154.02% over the past 52 weeks, while the S&P 500 index has gained 15.82% in the same period. RigNet (NASDAQ: RNET) shares gained...
Benzinga  Sep 4  Comment 
Sinovac Biotech (NASDAQ: SVA) shares gained 0.56% to touch a new 52-week high of $5.40. Sinovac Biotech shares have jumped 145.21% over the past 52 weeks, while the S&P 500 index has gained 16.84% in the same period. RetailMeNot (NASDAQ: SALE)...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki